A drug administered during ALS at a dose of 300 mg in 20 ml of 5% glucose solution, which is recommended in the treatment of ventricular and supraventricular arrhythmia, as well as in defibrillation-resistant ventricular fibrillation. Which of the following refers to this description?
Dział: Intensywna terapia
Odpowiedź na to pytanie oraz inne pytania z tego samego działu znajdziesz w aplikacji Egzamin LEK
